insights_auto
Kwa nini 524494 imepungua kwa 3.51%?
Fahamu zaidichevron_right
524494:BOM
IPCA Laboratories Ltd
₹ 1,845.00
arrow_downward
-3.51%(-67.20) Siku 1
16 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 524494...
Fungua
₹ 1,913.95
Juu
₹ 1,913.95
Chini
₹ 1,812.60
Mtaji wa soko
468.21B
Wastani wa kiasi cha mauzo
elfu 27.90
Kiasi cha mauzo ya hisa
elfu 12.00
Gawio
0.33%
Mgawo wa faida wa kila robo mwaka
₹ 1.50
Tarehe ya kutojumuisha gawio
7 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
35.74
Juu kwa wiki 52
₹ 2,039.30
Chini kwa wiki 52
₹ 1,252.95
EPS
₹ 51.63
Hisa za wawekezaji
126.35M
Idadi ya wafanyakazi
elfu 17
Fungua
₹ 1,913.95
Juu
₹ 1,913.95
Chini
₹ 1,812.60
Mtaji wa soko
468.21B
Wastani wa kiasi cha mauzo
elfu 27.90
Kiasi cha mauzo ya hisa
elfu 12.00
Gawio
0.33%
Mgawo wa faida wa kila robo mwaka
₹ 1.50
Tarehe ya kutojumuisha gawio
7 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
35.74
Juu kwa wiki 52
₹ 2,039.30
Chini kwa wiki 52
₹ 1,252.95
EPS
₹ 51.63
Hisa za wawekezaji
126.35M
Idadi ya wafanyakazi
elfu 17
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
tech-insider.org
·
saa 1 iliyopita
Trump Calls AI Warnings ‘HOAX’, Nasdaq Drops 0.9% [2026]
Yahoo Finance
·
saa 16 zilizopita
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
siku 1 iliyopita
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Investor's Business Daily
·
saa 4 zilizopita
Dow Jones Futures: What To Do After S&P 500, Nasdaq Break Support; Will Meta Earnings Save AI?
Wasifu
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Kuhusu IPCA Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 17.2
Lilianzishwa19 Okt 1949
Makao makuu-
Sekta-
Tovutiipca.com